Publications (1)2.27 Total impact
-
Article: Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.
Acta oncologica (Stockholm, Sweden) 10/2009; 49(1):109-10. · 2.27 Impact Factor